Presgo® Detachable Coil received the NMPA registration certificate in June 2018 (Guo Xie Zhu Zhun 20183770228) and was subsequently commercialized in China in October 2019. Presgo® Detachable Coil was recognized as a Shanghai Innovative Biomedical Product in 2019. The Company obtained the approval in Brazil for Presgo® Detachable Coil in December 2019(07.326.871/0002-20).
This product is used for the treatment of cerebral aneurysm and dural arteriovenous fistula. It can be directly inserted into the target position. It disconnects from the delivery system mechanically and is then left behind in the aneurysm. The coil then causes an intratumoral thrombus, which prevents the aneurysm from further expanding or breaking. In the meantime, endothelial cells start to cover the aneurysm neck so that the aneurysm is cured.
Presgo® Detachable Coil consists of two parts, the coil and the delivery system. The design of Presgo® Detachable Coil: 1) can be operated without using any additional detachment device or accessory and 2) it can be released instantly, which facilitates and shortens the procedure 3) certain models of Presgo® Detachable Coil can be as long as 80cm, which further reduces both cost and duration of procedures.